Are Akorn, Inc. (AKRX), CONN’s, Inc. (CONN), and MABVAX THERAPEUTICS (MBVX) Smart Investment Options?

Posted by admin December 17, 2014 0 Comment 1295 views

New York, NY – GDP INSIDER  –  12/17/2014.

This investment analysis article discusses Akorn, Inc.(NASDAQ:AKRX), CONN’s, Inc.(NASDAQ:CONN), and MABVAX THERAPEUTICS(OTCMKTS:MBVX)

Akorn, Inc.(NASDAQ:AKRX) has traded within a range of $20.52 to $45.25 over the past 52 weeks, but finished yesterday’s trading at a closing price of $37.55 after a 5.46% loss of $2.17. Despite the loss, Akorn appears to be a relatively stable investment. This claim is further reinforced by the company’s beta of 0.38, which indicates that the stock is 62% less volatile than the market. Additionally, Akorn also had a bid price of $37.30 x 300 and an offer prices of $38.50 on Dec. 16th, 2014.

Is Akorn Inc. A Winner? Get A Jump On Wall Street With Our Free AKRX Analysis.

CONN’s, Inc.(NASDAQ:CONN) is currently facing a class action lawsuit from purchases of its securities between Sept. 2nd, 2014 and Dec. 9th, 2014. The claim of the lawsuit is that the company misled investors and did not properly inform them of the “deterioration” of its credit portfolio. The company traded for a new 52 week low of $14.02 yesterday, a market which is $66.32 below its high of $80.34 for the same period. The company has an earnings per share (TTM) of $1.92, a price to earnings ratio (TTM) of $7.37, and a market capitalization of $513.14 million.

Could CONN’s Collapse? Make A Smart Investment Decision With Our Free CONN Analysis.

MABVAX THERAPEUTICS(OTCMKTS:MBVX) was recently selected to make a presentation in the public company program at the BIOTECH Showcase event. During the presentation, which will be held on Jan. 14th, 2014 in the San Francisco Wyndham Hotel, the company will provide a corporate update. The company has an abysmal earnings per share (TTM) of $–11.18, which could scare off investors. Additionally, MabVax also has a one-year target estimate of $1.05, which is $1.20 below its current closing price of $0.90. Considering the fact that the stock lost ninety cents yesterday, caution is warranted.

Should Day Traders Consider MabVax? Learn More About MBVX’s Trajectory With Our Free Analysis.

About HotStockGains provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit for complete risks and disclosures.

Write Your Comment